Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Precision Trials
mi
from
Phoenix, AZ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Precision Trials
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Visions Clinical Research Tuscon
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Descanso OBGYN
mi
from
Glendale, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Descanso OBGYN
mi
from
Glendale, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Woodglen Medical Group
mi
from
Glendora, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Woodglen Medical Group
mi
from
Glendora, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
White Memorial GYN/OB Medical Group
mi
from
Los Angeles, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
White Memorial GYN/OB Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Fair Oaks Women's Health
mi
from
Pasadena, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Fair Oaks Women's Health
mi
from
Pasadena, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
West Coast OBGYN
mi
from
San Diego, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
West Coast OBGYN
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
IGO Medical Group
mi
from
San Diego, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
IGO Medical Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Women's Health Care Research
mi
from
San Diego, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Women's Health Care Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Women's Clinical Research
mi
from
Vista, CA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Women's Clinical Research
mi
from
Vista, CA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Hawaii Pacific Health
mi
from
Honolulu, HI
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Hawaii Pacific Health
mi
from
Honolulu, HI
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Iowa Health Care
mi
from
Iowa City, IA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Iowa Health Care
mi
from
Iowa City, IA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Spectrum Health - Maternal Fetal Medicine
mi
from
Grand Rapids, MI
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Spectrum Health - Maternal Fetal Medicine
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Moorestown, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Mt. Holly, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Mt. Holly, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Saint Peter's Hospital
mi
from
New Brunswick, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Saint Peter's Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Sewell, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Sewell, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Virtua Health
mi
from
Voorhees, NJ
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Virtua Health
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Providence Health Partners-Center for Clinical Research
mi
from
Dayton, OH
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Providence Health Partners-Center for Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Medical University of South Carolina
mi
from
Charleston, SC
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
Magnolia OB/GYN Research Center- Recruiting
mi
from
Myrtle Beach, SC
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Magnolia OB/GYN Research Center- Recruiting
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  4/18/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx Trisomy Test in Pregnant Women at Low Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated:  4/18/2016
Los Angeles Biomedical Research
mi
from
Torrance, CA
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated: 4/18/2016
Los Angeles Biomedical Research
mi
from
Torrance, CA
Click here to add this to my saved trials
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated:  4/18/2016
University of Minnesota Department of Pediatrics
mi
from
Minneapolis, MN
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated: 4/18/2016
University of Minnesota Department of Pediatrics
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated:  4/18/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated: 4/18/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated:  4/18/2016
Hospital Universitario Austral A Unidad de Investigacion
mi
from
Buenos Aires,
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease
Status: Enrolling
Updated: 4/18/2016
Hospital Universitario Austral A Unidad de Investigacion
mi
from
Buenos Aires,
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's National Health System
mi
from
Washington,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Click here to add this to my saved trials
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
Healing Rate of Chronic and Sub-Acute Lower Extremity Ulcers Treated With Contact Ultrasound Followed by MIST Therapy: The VIP Ultrasound Protocol
Status: Enrolling
Updated:  4/19/2016
Texas Health Resources - Presbyterian Hospital of Dallas
mi
from
Dallas, TX
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
Healing Rate of Chronic and Sub-Acute Lower Extremity Ulcers Treated With Contact Ultrasound Followed by MIST Therapy: The VIP Ultrasound Protocol
Status: Enrolling
Updated: 4/19/2016
Texas Health Resources - Presbyterian Hospital of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Continuous Glucose Monitoring (POC) in the ICU
Continuous Glucose Monitors (CGM) Versus Point-of-Care (POC) Glucometers in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  4/28/2016
U.S. Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
Continuous Glucose Monitoring (POC) in the ICU
Continuous Glucose Monitors (CGM) Versus Point-of-Care (POC) Glucometers in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 4/28/2016
U.S. Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated:  5/10/2016
University of Michigan
mi
from
Ann Arbor, MI
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated: 5/10/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Analgesic Effect of IV Acetaminophen in Tonsillectomies
Analgesic Effect of Single Dose Intravenous Acetaminophen in Pediatric Patients Undergoing Tonsillectomy
Status: Enrolling
Updated:  5/10/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Analgesic Effect of IV Acetaminophen in Tonsillectomies
Analgesic Effect of Single Dose Intravenous Acetaminophen in Pediatric Patients Undergoing Tonsillectomy
Status: Enrolling
Updated: 5/10/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated:  5/11/2016
Clinical Research Facility
mi
from
Mountlake Terrace, WA
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 5/11/2016
Clinical Research Facility
mi
from
Mountlake Terrace, WA
Click here to add this to my saved trials
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated:  5/11/2016
mi
from
Liege,
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Status: Enrolling
Updated: 5/11/2016
mi
from
Liege,
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Arizona Allergy Associates
mi
from
Chandler, AZ
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Arizona Allergy Associates
mi
from
Chandler, AZ
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Miller Children's Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
UCLA Medical Center
mi
from
Los Angeles, CA
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
IMMUNOe International Research Centers
mi
from
Centennial, CO
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
IMMUNOe International Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Allergy Associates of the Palm Beaches, PA
mi
from
N Palm Beach, FL
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Allergy Associates of the Palm Beaches, PA
mi
from
N Palm Beach, FL
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Rush University Medical Center
mi
from
Chicago, IL
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Institute for Asthma and Allergy, P.C.
mi
from
Chevy Chase, MD
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Institute for Asthma and Allergy, P.C.
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Asthma and Allergy Center
mi
from
Toledo, OH
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Asthma and Allergy Center
mi
from
Toledo, OH
Click here to add this to my saved trials